A Observational Study to Evaluate Lipid-lowering Drug Its Effect on Parameters in Dyslipidemia of Type 2 Diabetes.

Inclusion Criteria: Among the patients, who has been hospitalized or visited the Outpatient Department OPD, who has dyslipidemia of type 2 diabetes. 1. Patients have the result of lipid parameter test at baseline and after lipid-lowering drug for at least 3 months. 2. Patients who have the result of lipid paraneter test (LDL-C ≥100mg/dL, TG ≥150mg/dL) at baseline. 3. Patients who have no received lipid lowering drug fr at least 2 months prior to the baseline. 4. Patients' age were \> 20 years and \<75 year. Exclusion Criteria: 1. Patients who ahs HbA1c≥9% 2. Patients who have no the result of lipid parameter test at baseline and at baseline and after lipid-lowering drug for at least 3 months 3. Patients who have history of drug discontinuation by incresed liver enzyme or rhabdomyolysis. 4. Patients received lipid-lowering drug and TZD(Thiazolidinediones) in study period 5. Renal abnormality 6. Alcoholism or Alcohol abuse 7. Patients treated by Steroids. 8. Pregnant or lactating woman 9. Patients who are judged as not suitable for this study by Investigator.